Phaseline

Companies › Zhuhai United Laboratories

Zhuhai United Laboratories: clinical trials, targets and expected readouts

1 active drug program in 1 registered trial: 1 Phase 1; Hematology; next expected readout May 2027.

Open in Phaseline: competitors, likelihood bands and readouts Company report

Programs

DrugTargetHighest phaseConditionsNext expected readout
TUL321–Phase 1Paroxysmal Nocturnal Hemoglobinuria, PNHMay 2027

Trials

Registry idDrugPhaseConditionsAreaExpected readout
NCT07760467TUL321Phase 1Paroxysmal Nocturnal Hemoglobinuria, PNHHematologyMay 2027

Targets

No annotated target.

Companies with the same targets

–

Programs group the company's trials by drug; the target and mechanism come from Open Targets and ChEMBL via Open Targets; expected readouts are Phaseline's estimate from the registry's primary completion date. Facts from the registries only; the approval likelihood, shown as a band with its track record, is in the app.